News

Capricor says FDA inspection brought Form 483 with several observations
Capricor Therapeutics (CAPR) announced the completion of the Food and Drug Administration’s pre-license inspection of its San ...
Sun Pharma’s Halol facility issued eight observations by U.S. FDA
Sun Pharmaceutical Industries’ drug manufacturing facility in Halol, Gujarat, has been issued eight observations by the U.S. Food and Drug Administration (FDA).
Medical Dialogues13d
Alembic Pharma gets four USFDA observations for Panelav facility
Vadodara: Alembic Pharma has announced that the United States Food and Drug Administration (US FDA) has issued four ...
Pharmabiz5d
OneSource's flagship drug-device combination facility maintains its US FDA compliance status
OneSource's flagship drug-device combination facility maintains its US FDA compliance status: Our Bureau, Bengaluru Tuesday, June 10, 2025, 11:45 Hrs [IST] OneSource Specialty Pha ...